
Merck and Moderna's mRNA vaccine cuts melanoma recurrence
Merck and Moderna released trial results showing their personalised mRNA vaccine, given with an existing immunotherapy, significantly reduced cancer recurrence and death in patients with melanoma. NPR says it is the biggest test yet of the mRNA cancer vaccine concept.
Read more at NPR →













